Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
Part of paid clinical trials in Addison, Illinois.
- Sponsor
- Midwest Center for Metabolic and Cardiovascular Research
- Study ID
- NCT07514663
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 74 Years
- Healthy Volunteers
- Accepted
Interventions
- corn oil — OTHERCorn oil will be provided in yogurt, rolls and muffins throughout the study period.
- Avocado Oil — OTHERAvocado oil will be provided in yogurt, rolls and muffins throughout the study period.
Study Details
The goal of this clinical trial is to assess the effects of corn and avocado oils as part of controlled feeding diets on the cardiometabolic risk factor profile in men and women with mild-to-moderately elevated levels of non-high-density lipoprotein cholesterol (non-HDL-C). Participants will be asked to consume the controlled feeding diet for two separate 21 day conditions, and will consume their regular diet for a 21 day washout period between the two conditions. Additionally, participants will be asked to come into the clinic on 7 different occasions, including one screening visit (visit 1, -7 days), one baseline visit (visit 2, day 0), two visits during each 21-d diet condition (visits 3 \& 6, day 19 and visits 4 \& 7, day 21), and a visit at the conclusion of the washout phase/start of the second diet condition (visit 5, day 0).
Key Dates
- Start date
- Apr 10, 2026
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 54 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Corn OilCorn oil (4 tablespoons/d) will be provided in 3 servings of study products per day (yogurt, dinner roll, and muffin).
- Active Comparator: Avocado OilAvocado oil (4 tablespoons/d) will be provided in 3 servings of study products per day (yogurt, dinner roll, and muffin).
Primary Outcome Measure
Non-high density lipoprotein cholesterol (non-HDL-C) [ Time Frame: Baseline (day 0) to end of each condition (day 21) ]
Central Contacts
- Caryn Adams, MPH630-469-6600
- Sara Campbell, MPH630-469-6600
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Biofortis Clinical Research | Addison | Illinois | 60101 |
Find similar trials in Addison, IL
Related Studies
- Causes and Natural History of DyslipidemiasRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Alirocumab in Patients on a Stable Dialysis RegimenPHASE3 · Recruiting · Baylor Research Institute · Dallas, Texas
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders TrialPHASE2 · Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Pharmacogenomic Informed Statin PrescribingRecruiting · VA Office of Research and Development · Indianapolis, Indiana